about
Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised TrialPharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster featuresGeneralized enrichment analysis improves the detection of adverse drug events from the biomedical literaturePharmacovigilance Skills, Knowledge and Attitudes in our Future Doctors - A Nationwide Study in the Netherlands.Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review.Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study.Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseasesAn evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim.Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.Are primary care factors associated with hospital episodes for adverse drug reactions? A national observational study.Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation.Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol.Patient Characteristics Associated with Adverse Drug Events in Hospital: An Overview of ReviewsAn analysis of serious adverse drug reactions at a tertiary care teaching hospitalPharmacovigilance in Calabria (Italy): Local experiences resonate international relevance.Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study.The emerging era of pharmacogenomics: current successes, future potential, and challenges.Adherence to therapy and adverse drug reactions: is there a link?Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts.Pharmacometabonomics in humans: a new tool for personalized medicine.Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review.Pharmacovigilance in resource-limited countries.L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada.The emergence of precision therapeutics: New challenges and opportunities for Canada's health leaders.The key role of clinical and community health nurses in pharmacovigilance.Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists' attitudes following an awareness workshop.Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.Testing an explanatory model of nurses' intention to report adverse drug reactions in hospital settings.β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.Prescribing indicators in primary health care in Belo Horizonte, Brazil: associated factors.Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.Adverse drug reactions experience in a teaching hospital in Jordan.Risk factors for adverse drug reactions in pediatric inpatients: A cohort study.Models of Models: A Translational Route for Cancer Treatment and Drug Development.Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.Use of a trigger tool to detect adverse drug reactions in an emergency department.Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models.
P2860
Q28550194-F2DD193A-2A4B-41E5-9455-39FC5673DB78Q28645804-3120D78C-4FA3-4F96-A28E-88ACED6C3908Q28829259-E9069D7E-F554-4505-A908-367A149C100CQ30151585-1FD3ABA1-0CE7-4B83-8A78-4CFE08AEBB9AQ30235515-2314ED5F-9925-4E4B-B197-CEE1F20BB4EDQ30844583-D112E39D-4C5E-4823-8A63-F8E27BC82C6AQ33420661-7ABE48A6-CB2C-4857-AF57-5D876A517EF4Q33807984-C7D5AB1D-6DF6-4305-8BEA-D9ED50988AFDQ36266602-6D82A67A-FFA6-4D75-AC02-8BC586B0FF9DQ36391044-C8BE3AA0-0AE1-461D-9D56-E6941F3F9510Q36456927-5B3B8FB4-1049-4A53-B5A3-DD810A64E8F3Q36761515-A82ECCFC-4390-4ED2-88F2-8E80563AA34AQ36820381-6CA98815-B8BD-44E8-B975-3F3208F7E658Q37225741-B2503DD4-D032-4C0D-9A3B-C3FF8219955EQ37364594-575EF214-AE4C-4D73-A6FD-E0386B804A6DQ37369618-7701E881-985D-49C8-9C7D-7969768251F9Q37399578-42E2F810-B148-4FC9-9AD9-E700E515A229Q38200683-6B879239-5514-4E73-BA1B-0BB0EC654000Q38244574-C4C2958A-0D86-450D-B72A-6DDA16C6A521Q38379019-A3593E9A-71E7-4AD9-8A5D-6D8C72353587Q38452107-E7E2FC05-850E-4172-8D3B-3206F025942CQ38479788-E1ED7FB0-575F-4667-857C-910F52F14DB0Q38514950-2BCE98B4-0D11-455F-BCF2-F7F69CC5D27BQ38612876-4DD47B1B-0F9A-4D28-9A90-F9323019E04FQ38612881-05F20081-274A-4E85-96D9-81C7815452A6Q38645302-0EBB64C9-22AF-4696-876B-C11BBB556EC1Q38681717-E3617DAA-BC50-46D0-A74E-7B0E96C87946Q38732374-63876F1C-7B65-4881-8513-B6AEC56F5C64Q38870751-561078C1-B9BD-4041-A2C0-1F13FC2DFA27Q38941642-210275BA-BB98-4F8F-A03F-419FA7043BEEQ38996062-EC3B130E-57E1-469F-87A8-1D083ACABF0CQ39051288-8C1E6504-9B6C-4C19-BA7A-15082B701E8FQ39381885-7F542179-33C6-46C8-87A1-C108188C522AQ40125010-6DE33C5C-2E60-4A9D-809E-165EDAC18BBFQ40142716-050F9030-3895-4653-8B79-9787C5083334Q41200319-C8D1A7CC-9A44-4A0B-B26A-69379F8ACE75Q41833969-F576E13A-7F54-4A02-B32C-0A4FC0B75D30Q43456235-5C3CD534-7EEF-484B-A1F8-781BAB2947A5Q45902688-60318659-A638-4FB6-A167-4FC54558E414Q45945293-49CD5617-2F11-43D2-9367-9729E8E8D73A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and economic burden of adverse drug reactions
@en
Clinical and economic burden of adverse drug reactions.
@nl
type
label
Clinical and economic burden of adverse drug reactions
@en
Clinical and economic burden of adverse drug reactions.
@nl
prefLabel
Clinical and economic burden of adverse drug reactions
@en
Clinical and economic burden of adverse drug reactions.
@nl
P2860
P356
P1476
Clinical and economic burden of adverse drug reactions
@en
P2093
Gianluca Trifirò
P2860
P356
10.4103/0976-500X.120957
P433
P577
2013-12-01T00:00:00Z